Skip to content

RNA

Avidity Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.64
−0.97%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
15.26x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.69x
Price / sales
6.29x
Price / cash flow
-3.59x

Enterprise value

Enterprise value
-$114.8M
EV / sales
-4.89x
EV / EBITDA
1.21x
EV / EBIT
1.19x
Market cap
$147.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026